SPDR S&P Biotech ETF (NYSEARCA:XBI) Reaches New 1-Year High – Here’s What Happened

Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $169.89 and last traded at $169.40, with a volume of 4220462 shares. The stock had previously closed at $164.17.

SPDR S&P Biotech ETF Stock Performance

The stock has a fifty day moving average of $154.55 and a 200-day moving average of $138.02. The company has a market cap of $11.03 billion, a PE ratio of 11.47 and a beta of 0.83.

Institutional Trading of SPDR S&P Biotech ETF

A number of large investors have recently made changes to their positions in XBI. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $256,053,000. Bank of America Corp DE boosted its position in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares in the last quarter. Wells Fargo & Company MN grew its stake in SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp raised its holdings in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after purchasing an additional 1,187,907 shares in the last quarter. Finally, Morgan Stanley raised its holdings in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares in the last quarter.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.